Playing the EU Funding Game

Volume 16 | Issue 13 | 40 | Jun. 24, 2002 Previous | Next Playing the EU Funding Game They've got the money; you've got the need. Here's how to align your interest with the bureaucrats in Brussels | By Sam Jaffe Image: Marlene J. Viola Protests against McDonalds and high tariffs against Hollywood movies suggest that Europe fights hard to defend its traditions and heritage against US cultural

Written bySam Jaffe
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Protests against McDonalds and high tariffs against Hollywood movies suggest that Europe fights hard to defend its traditions and heritage against US cultural assaults. But the Old World nations would love to imitate the States in one area: science funding. Institutions like the National Institutes of Health and the National Science Foundation allow scientists in the United States to dominate global research.

To give European scientists a better edge, the Sixth Framework Programme, a four-year project of the European Union, will provide ¤17.5 billion for research throughout the 15-state EU. Of that total, at least ¤2.3 billion have been set aside for life sciences research, and that's on top of funding resources from each member country.

But it takes more than simply asking if you want a share of the EU pie. "Never go to Brussels looking for money. Instead, go to [the EU] with a solution to [a] problem," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies